Table 3.
Functional annotations with over-representation of mutations in all Ewing samples, together with the level of significance and the genes that significantly affect the enrichment statistics calculated by the GSEA program (Reactome or Hallmark)
Pathway | Genes | Significance (false discovery rate, %) | Dataset |
---|---|---|---|
G2/M DNA damage checkpoint | TP53, ATM, CHEK1, ATR, NBN, BRCA1, RAD50 | <25 | Reactome |
Pre-NOTCH EXPRESSION AND PROCESSING | NOTCH1, TP53, CREBBP, NOTCH2, NOTCH3 | < 25 | |
DNA repair |
POLE, TP53, BRCA2, ATM, MSH2, MLH1, CHEK1, MSH6, ATR, NBN, BRCA1, RAD50, BAP1, FANCI, FANCA, PALB2 |
< 25 | |
DNA double-strand break repair | POLE, TP53, BRCA2, ATM, CHEK1, ATR, NBN, BRCA1, RAD50, BAP1 | < 25 | |
Cell cycle progression: E2F targets (E2F_TARGETS) | POLE, TP53, BRCA2, MSH2, MLH1, CHEK1, NBN, BRCA1, RAD50 | < 25 | Hallmark |
Cell cycle progression: G2/M checkpoint (G2M_CHECKPOINT) |
POLE, BRCA2, ATRX, NOTCH2, CHEK1 | < 25 | |
Canonical beta-catenin pathway (WNT_BETA_CATENIN_SIGNALING) |
NOTCH1, TP53, PTCH1 | < 25 | |
Genes important for mitotic spindle assembly (MITOTIC_SPINDLE) | NF1, BRCA2, NOTCH2, TSC1 | < 25 |